³Ô¹Ï±¬ÁÏ Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
PLEASANTON, CA ¡ª Sept. 1, 2026 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.
In addition to working seamlessly with ³Ô¹Ï±¬ÁÏ Safety, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.
"We¡¯ve had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build ³Ô¹Ï±¬ÁÏ Safety," said Marius Mortensen, vice president of product, Falcon at ³Ô¹Ï±¬ÁÏ. "With Falcon Safety, we¡¯re excited to build on that partnership to help the industry reinvent safety operations."
Planned for early adopter availability in November 2026, Falcon Safety is part of ³Ô¹Ï±¬ÁÏ AI, ³Ô¹Ï±¬ÁÏ¡¯s industry-specific AI solutions for life sciences.
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Contact:
Elizabeth McGrane
³Ô¹Ï±¬ÁÏ Systems
elizabeth.mcgrane@veeva.com
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems, Europe
jeremy.whittaker@veeva.com